Healthcare-Focused Secondaries Manager Revelation Partners Adds Kudu Investment Management as Strategic Partner
Revelation Partners (Revelation), a leading investment manager in the healthcare secondaries market, and Kudu Investment Management, LLC (Kudu), a provider of permanent capital solutions to independent asset and wealth managers worldwide, today announced that Kudu has made a minority investment in Revelation. Financial terms were not disclosed.
Bluesight Expands Capabilities Through Acquisition of Sectyr
Bluesight, the leading provider of Medication Intelligence™ solutions for health systems and hospital pharmacies, announced the acquisition of Sectyr, a top-tier compliance and audit management platform. This acquisition expands Bluesight’s portfolio to include robust 340B audit and compliance tools in response to growing demand from its customers.
Revelation Partners Deepens Healthcare Expertise with Two New Hires
Revelation Partners, the largest investment firm dedicated to healthcare secondaries, is pleased to announce the addition of two new investment team members. The firm welcomes Chris Bayliss as Vice President, along with Vicky Valverde as Associate. With over $1.5 billion of capital under management, Revelation Partners has evaluated over $1.3 billion of healthcare investment opportunities this year. Revelation Partners provides liquidity to parties […]
Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical Inc., a privately held company providing a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis. “We are committed to helping customers restore patients’ quality of life with interventional solutions to address chronic […]
Amidst a Fight for Survival, Liquidity Tools Provide a Golden Opportunity to Emerging Managers in Healthcare
In mid-2023, we published a report on how a secondary strategy can assist GPs in raising capital. We touched upon the challenging fundraising environment that emerging managers face and how continuation vehicles are evolving to cater to the needs of emerging managers as they seek to establish a track record of distributions for LPs. In […]
Crown Laboratories and Revance Announce Entry Into Merger Agreement
Crown Laboratories, Inc. (“Crown”), a privately held, global innovative leader in the skincare industry, and Revance Therapeutics, Inc. (“Revance”) (NASDAQ: RVNC), a biotechnology company aimed at setting the new standard in healthcare with innovative aesthetic and therapeutic offerings, today announced that they have entered into a merger agreement pursuant to which the companies seek to merge the […]
Secondary Transactions for Healthcare Private Equity
Written in collaboration with PJT Park Hill, in this white paper, we cover: Watch a short video on why more GPs are considering continuation vehicles:
Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer
Dren Bio, Inc. (“Dren Bio” or the “Company”), a privately held, clinical-stage biopharmaceutical company developing antibody therapeutics for cancer, autoimmune, and other serious diseases, today announced that it has entered into a strategic collaboration with Novartis Pharma AG, a subsidiary of Novartis AG (NYSE: NVS). The collaboration will focus on the discovery and development of […]
Artiva Shares Jump 30% After Upsized $167 Million US IPO
Artiva Biotherapeutics Inc. shares pared initial gains to end flat in the company’s trading debut after raising $167 million in an expanded initial public offering. Shares of the clinical stage biotechnology company, backed by South Korea’s Green Cross Corp., traded as high as $16 each before retreating to their $12 IPO price on Friday in New York.
Arcadia Acquires CareJourney to Enable High-performing Networks and Value-based Care Success
Arcadia® (arcadia.io), a leading data platform for healthcare, announced today the acquisition of CareJourney®, a preeminent provider of clinically relevant healthcare data and AI-powered analytics and insights. This strategic acquisition blends Arcadia’s next-generation healthcare data platform, proprietary analytics, and workflow tools with CareJourney’s cost, quality, and benchmark data. CareJourney derives market-leading analytics from Medicare, Medicaid, […]